Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention

Nicolás A. Giraldo, Esther Drill, Baby A. Satravada, Imane El Dika, A. Rose Brannon, Josephine K. Dermawan, Abhinita Mohanty, Kerem Özcan, Debyani Chakravarty, Ryma Benayed, Efsevia Vakiani, Ghassan K. Abou‐Alfa, Ritika Kundra, Nikolaus Schultz, Bob T. Li, Michael F. Berger, James J. Harding, Marc Ladanyi, Eileen M. O’Reilly, William R. Jarnagin, Chad Vanderbilt, Olca Baştürk, Maria E. ArcilaClinical 2022 · DOI

Abstract

GBC is a genetically diverse malignancy. This large-scale genomic analysis revealed alterations with potential prognostic and therapeutic implications and provides guidance for the development of targeted therapies.
BibTeX
@inproceedings{giraldo2022comprehensive,
  author = {Nicolás A. Giraldo and Esther Drill and Baby A. Satravada and Imane El Dika and A. Rose Brannon and Josephine K. Dermawan and Abhinita Mohanty and Kerem Özcan and Debyani Chakravarty and Ryma Benayed and Efsevia Vakiani and Ghassan K. Abou‐Alfa and Ritika Kundra and Nikolaus Schultz and Bob T. Li and Michael F. Berger and James J. Harding and Marc Ladanyi and Eileen M. O’Reilly and William R. Jarnagin and Chad Vanderbilt and Olca Baştürk and Maria E. Arcila},
  title = {{Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention}},
  booktitle = {Clinical},
  year = {2022},
  doi = {10.1158/1078-0432.ccr-22-1954},
}

Loading related content...

Figure